Joshua Brody, Director of Lymphoma Immunotherapy Program and Associate Professor of Division of Hematology and Oncology at Icahn School of Medicine at Mount Sinai, shared a post on LinkedIn about he co-authored with colleagues published in Methods in Cell Biology:
“Cool, quick summary of by Moah Sohn on how to CRISPR edit T-cells to understand and improve them for cancer immunotherapy.”
“Mouse and human T cell Cas9-RNP/nucleofection-mediated gene-editing”
Authors: Moah Sohn, Gvantsa Pantsulaia, Joshua Brody.
More posts featuring Joshua Brody.
